作为CRSwNP严重程度的标志物,表皮内透的埃索诺菲尔杆细胞模式是CRSwNP严重性的标志
Matteo Gelardi1, Rossana Giancaspro2, Loren Duda3
1Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122, Foggia, Italy.
Scientific reports
|July 26, 2023
概括
鼻息肉中的母细胞 (MCs) 与严重性鼻息肉 (CRSwNP) 的慢性鼻炎相关. 内皮质MCs表明更严重的疾病,建议为量身定制的治疗提供新的诊断标准.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 带有鼻息肉的慢性鼻炎 (CRSwNP) 是一种2型异性疾病.
- 乳腺细胞 (MCs) 在CRSwNP病原发生中的作用未被充分认识到.
- CRSwNP的混合埃索诺菲尔-MC形式显示出更高的复发风险.
研究的目的:
- 为了研究鼻聚体中巨细胞 (MCs) 的存在和局部.
- 为了将MCs与CRSwNP严重程度和埃索诺菲尔细胞计数相关联.
- 为了比较细胞学和组织病理学方法用于MC检测.
主要方法:
- 对39个鼻息肉样本进行了组织病理学和细胞学检查.
- 在上皮层和膜自身层中,酸酶+CD117+MCs的免疫组织化学.
- 统计分析以确定相关性和切线值.
主要成果:
- 皮质内MC和CRSwNP严重程度 (p<0.001) 之间存在显著的相关性.
- 总胆固醇和总MC计数有显著的相关性 (p<0.001).
- 细胞学和免疫组织化学显示出可比的内皮细胞MC检测 (p=0.002).
- 6个内皮质MC的切断线确定了严重的CRSwNP (p<0.001).
- 拉米纳自身MCs在乙性CRSwNP中很常见,但与严重程度无关.
结论:
- 内皮质巨细胞与CRSwNP严重程度的增加显著相关.
- 应确定对CRSwNP的异osinophil-MC形式的组织病理学标准.
- 定义这些标准可以导致更有效,个性化的患者治疗.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
348
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
348


